High-risk endometrial cancer

Clinical trials for High-risk endometrial cancer explained in plain language.

Never miss a new study

Get alerted when new High-risk endometrial cancer trials appear

Sign up with your email to follow new studies for High-risk endometrial cancer, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet finished but already full! 1

Immunotherapy combo shows promise in preventing High-Risk uterine cancer return

Disease control Ongoing

This study tests whether adding the immunotherapy drug pembrolizumab to standard chemotherapy (with or without radiation) after surgery can help prevent high-risk endometrial cancer from coming back. About 990 participants who had surgery to remove their uterus and ovaries will r…

Matched conditions: HIGH-RISK ENDOMETRIAL CANCER

Phase 3 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control

Last updated Jul 26, 2026 00:00 UTC

High-risk endometrial cancer

Get alerted when new High-risk endometrial cancer trials appear

Immunotherapy combo shows promise in preventing High-Risk uterine cancer return